IDO1 and neoplasm: IDO1 and TDO can be expressed constitutively by cancer cells, in which case they inhibit lymphocyte infiltration, or expressed by cancer and stromal cells in response to IFNγ, which limits the activity of tumour-infiltrating lymphocytes (92).